Viet D. Vu

Array ( [id] => 3493085 [patent_doc_number] => 05536742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-16 [patent_title] => 'Anti-seborrhoeic formulation' [patent_app_type] => 1 [patent_app_number] => 8/211706 [patent_app_country] => US [patent_app_date] => 1994-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 903 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/536/05536742.pdf [firstpage_image] =>[orig_patent_app_number] => 211706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3559215 [patent_doc_number] => 05500434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-19 [patent_title] => 'Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs' [patent_app_type] => 1 [patent_app_number] => 8/225762 [patent_app_country] => US [patent_app_date] => 1994-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5648 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/500/05500434.pdf [firstpage_image] =>[orig_patent_app_number] => 225762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3698845 [patent_doc_number] => 05677331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Antimalarial compositions' [patent_app_type] => 1 [patent_app_number] => 8/216440 [patent_app_country] => US [patent_app_date] => 1994-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4464 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677331.pdf [firstpage_image] =>[orig_patent_app_number] => 216440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658859 [patent_doc_number] => 05627172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Method for reduction of serum blood lipids or lipoprotein fraction' [patent_app_type] => 1 [patent_app_number] => 8/206089 [patent_app_country] => US [patent_app_date] => 1994-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2450 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627172.pdf [firstpage_image] =>[orig_patent_app_number] => 206089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3539084 [patent_doc_number] => 05494914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'Inhibitors for testosterone 5.alpha.-reductase activity' [patent_app_type] => 1 [patent_app_number] => 8/196332 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15230 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494914.pdf [firstpage_image] =>[orig_patent_app_number] => 196332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3037792 [patent_doc_number] => 05373010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-13 [patent_title] => 'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives' [patent_app_type] => 1 [patent_app_number] => 8/195184 [patent_app_country] => US [patent_app_date] => 1994-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8121 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/373/05373010.pdf [firstpage_image] =>[orig_patent_app_number] => 195184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3454041 [patent_doc_number] => 05451602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-19 [patent_title] => 'Cholecystokinin antagonists useful in the treatment of panic attcks' [patent_app_type] => 1 [patent_app_number] => 8/190401 [patent_app_country] => US [patent_app_date] => 1994-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9441 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/451/05451602.pdf [firstpage_image] =>[orig_patent_app_number] => 190401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3562078 [patent_doc_number] => 05525598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Gallium (III) complexes in pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 8/178241 [patent_app_country] => US [patent_app_date] => 1994-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4937 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525598.pdf [firstpage_image] =>[orig_patent_app_number] => 178241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3410975 [patent_doc_number] => 05461041 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Progestogen-only contraceptive' [patent_app_type] => 1 [patent_app_number] => 8/183644 [patent_app_country] => US [patent_app_date] => 1994-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1677 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/461/05461041.pdf [firstpage_image] =>[orig_patent_app_number] => 183644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3107220 [patent_doc_number] => 05418228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-23 [patent_title] => 'Contraceptive regimen' [patent_app_type] => 1 [patent_app_number] => 8/182304 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2287 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/418/05418228.pdf [firstpage_image] =>[orig_patent_app_number] => 182304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171702 [patent_doc_number] => 06140355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Pharmaceutical compositions containing rifaximin for treatment of vaginal infections' [patent_app_type] => 1 [patent_app_number] => 8/181259 [patent_app_country] => US [patent_app_date] => 1994-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5229 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140355.pdf [firstpage_image] =>[orig_patent_app_number] => 181259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3426245 [patent_doc_number] => 05416098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-16 [patent_title] => 'Method for treating dermatitis and related conditions' [patent_app_type] => 1 [patent_app_number] => 8/175840 [patent_app_country] => US [patent_app_date] => 1993-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3175 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/416/05416098.pdf [firstpage_image] =>[orig_patent_app_number] => 175840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3520140 [patent_doc_number] => 05530023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Production of binding sites for PAF, PAF analogues and PAF antagonists in endothelial cells' [patent_app_type] => 1 [patent_app_number] => 8/172234 [patent_app_country] => US [patent_app_date] => 1993-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6835 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/530/05530023.pdf [firstpage_image] =>[orig_patent_app_number] => 172234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3420614 [patent_doc_number] => 05478857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-26 [patent_title] => 'Use of PLA.sub.2 inhibitors as treatment for alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/173544 [patent_app_country] => US [patent_app_date] => 1993-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18791 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/478/05478857.pdf [firstpage_image] =>[orig_patent_app_number] => 173544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3613837 [patent_doc_number] => 05534526 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome' [patent_app_type] => 1 [patent_app_number] => 8/173502 [patent_app_country] => US [patent_app_date] => 1993-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2913 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534526.pdf [firstpage_image] =>[orig_patent_app_number] => 173502 [rel_patent_id] =>[rel_patent_doc_number] =>)